Advertisement

Related Videos

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Sep
30
Today In Oncology
Cleveland Clinic to Host Second Annual AI Summit for Health-Care Professionals
Cleveland Clinic President Discusses AI Summit for Health-Care Professionals
AI’s Evolving Role in Clinical Care Enterprise-Wide
Long-Term Disease Control From SBRT Equal to Surgery in Localized Prostate Cancer
Cancer Statistics 2026: What Every Medical Oncologist Should Know
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo